MARKET

AYTU

AYTU

Aytu BioScience
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.290
0.000
0.00%
After Hours: 1.280 -0.01 -0.78% 19:58 08/14 EDT
OPEN
1.300
PREV CLOSE
1.290
HIGH
1.300
LOW
1.275
VOLUME
1.94M
TURNOVER
--
52 WEEK HIGH
2.990
52 WEEK LOW
0.3352
MARKET CAP
155.14M
P/E (TTM)
-0.8396
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AYTU stock price target is 2.750 with a high estimate of 3.000 and a low estimate of 2.500.

EPS

AYTU News

More
Aytu (AYTU) to Report Q4 Earnings: What's in the Cards?
Zacks · 08/04 16:56
Aytu Bioscience, Inc. (AYTU) Outpaces Stock Market Gains: What You Should Know
Zacks · 07/31 22:45
Aytu BioScience Announces Expansion Of NATESTO US Commercial Team
Commercial Partner Acerus Pharmaceuticals Launches Specialty Sales Team Calling on Urologists and Endocrinologists in the United States ENGLEWOOD, CO / ACCESSWIRE / July 20, 2020 / Aytu BioScience, Inc.
Benzinga · 07/20 11:36
Aytu Bio expands U.S. distribution of COVID-19 blood test with Apollo deal
Seeking Alpha - Article · 07/10 12:14
Is Aytu Bioscience (AYTU) Stock Outpacing Its Medical Peers This Year?
Zacks · 07/07 16:30
INO, DVAX among premarket gainers
Seeking Alpha - Article · 06/26 12:21
All You Need to Know About Aytu Bioscience, Inc. (AYTU) Rating Upgrade to Strong Buy
Zacks · 06/25 17:00
ASLAN Pharmaceuticals (ASLN) Looks Good: Stock Adds 8.7% in Session
Zacks · 06/25 13:50

Industry

Biotechnology & Medical Research
-0.54%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Symbol
Price
%Change

About AYTU

Aytu BioScience, Inc. is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The primary care portfolio includes Natesto, the nasal formulation of testosterone for men with hypogonadism, ZolpiMist, the oral spray prescription sleep aid, and Tuzistra XR, the 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, a granule formulation of rabeprazole sodium, a commonly prescribed proton pump inhibitor; Cefaclor, a second-generation cephalosporin antibiotic suspension; Karbinal ER, an extended-release carbinoxamine suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various for infants and children with fluoride deficiency.
More

Webull offers kinds of Aytu Bioscience Inc stock information, including NASDAQ:AYTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYTU stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AYTU stock methods without spending real money on the virtual paper trading platform.